CardioDx, Inc. Blood-Based Gene Expression Test Honored As One Of TIME Magazine's Top Ten Medical Breakthroughs of 2010
PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, today announced that Corus™ CAD, the company’s blood-based gene expression test, has been honored as one of TIME Magazine’s Top Ten Medical Breakthroughs of 2010.